Perigon Wealth Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.48M | Buy |
24,409
+58
| +0.2% | +$14.5K | 0.1% | 201 |
|
|
2025
Q4 | $5.87M | Sell |
24,351
-131
| -0.5% | -$33.5K | 0.1% | 177 |
|
|
2025
Q3 | $6.7M | Buy |
24,482
+2,110
| +9% | +$576K | 0.14% | 149 |
|
|
2025
Q2 | $5.77M | Buy |
22,372
+10
| +0% | +$2.38K | 0.13% | 148 |
|
|
2025
Q1 | $5.01M | Sell |
22,362
-103
| -0.5% | -$24K | 0.13% | 160 |
|
|
2024
Q4 | $5.33M | Sell |
22,465
-1,668
| -7% | -$402K | 0.13% | 151 |
|
|
2024
Q3 | $5.89M | Sell |
24,133
-25
| -0.1% | -$5.59K | 0.16% | 136 |
|
|
2024
Q2 | $4.62M | Sell |
24,158
-362
| -1% | -$73.5K | 0.13% | 146 |
|
|
2024
Q1 | $4.86M | Sell |
24,520
-2,921
| -11% | -$535K | 0.15% | 143 |
|
|
2023
Q4 | $4.72M | Sell |
27,441
-734
| -3% | -$113K | 0.15% | 134 |
|
|
2023
Q3 | $4.17M | Sell |
28,175
-1,798
| -6% | -$325K | 0.17% | 128 |
|
|
2023
Q2 | $6.55M | Buy |
29,973
+267
| +0.9% | +$59.5K | 0.26% | 94 |
|
|
2023
Q1 | $6.51M | Buy |
29,706
+557
| +2% | +$121K | 0.37% | 64 |
|
|
2022
Q4 | $6.07M | Buy |
29,149
+2,863
| +11% | +$629K | 0.38% | 65 |
|
|
2022
Q3 | $5.74M | Sell |
26,286
-900
| -3% | -$205K | 0.5% | 41 |
|
|
2022
Q2 | $5.7M | Sell |
27,186
-34
| -0.1% | -$7.24K | 0.48% | 41 |
|
|
2022
Q1 | $6.6M | Buy |
27,220
+28
| +0.1% | +$6.77K | 0.47% | 39 |
|
|
2021
Q4 | $7.08M | Sell |
27,192
-294
| -1% | -$76.3K | 0.51% | 35 |
|
|
2021
Q3 | $7.24M | Buy |
27,486
+327
| +1% | +$89.4K | 0.63% | 30 |
|
|
2021
Q2 | $6.7M | Buy |
27,159
+32
| +0.1% | +$6.73K | 0.6% | 33 |
|
|
2021
Q1 | $5.26M | Buy |
27,127
+2,350
| +9% | +$471K | 0.54% | 37 |
|
|
2020
Q4 | $5.27M | Buy |
24,777
+92
| +0.4% | +$18.3K | 0.61% | 32 |
|
|
2020
Q3 | $4.23M | Sell |
24,685
-28
| -0.1% | -$5.17K | 0.59% | 35 |
|
|
2020
Q2 | $4.75M | Buy |
24,713
+801
| +3% | +$131K | 0.75% | 29 |
|
|
2020
Q1 | $3.82M | Buy |
23,912
+1,452
| +6% | +$231K | 0.71% | 35 |
|
|
2019
Q4 | $3.5M | Buy |
22,460
+2,400
| +12% | +$346K | 0.72% | 35 |
|
|
2019
Q3 | $2.62M | Buy |
20,060
+2,473
| +14% | +$324K | 0.61% | 40 |
|
|
2019
Q2 | $2.15M | Buy |
17,587
+1,235
| +8% | +$137K | 0.5% | 44 |
|
|
2019
Q1 | $1.67M | Buy |
16,352
+1,460
| +10% | +$151K | 0.39% | 49 |
|
|
2018
Q4 | $1.41M | Buy |
14,892
+90
| +0.6% | +$9.64K | 0.36% | 54 |
|
|
2018
Q3 | $1.71M | Buy |
14,802
+2,363
| +19% | +$259K | 0.42% | 49 |
|
|
2018
Q2 | $1.29M | Buy |
12,439
+11,504
| +1,230% | +$1.16M | 0.39% | 58 |
|
|
2018
Q1 | $92K | Buy |
+935
| New | +$88.4K | 0.03% | 237 |
|
|
2016
Q4 | – | Sell |
-100
| Closed | -$6K | – | 751 |
|
|
2016
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 539 |
|
|
2016
Q2 | $6K | Buy |
+100
| New | +$5.89K | ﹤0.01% | 393 |
|
Other funds holding RMD
VCM
VPM
DAM
Perigon Wealth Management's RMD Position: Q1 2026 in Review
Perigon Wealth Management increased its ResMed (RMD) stake by 0.24% in Q1 2026, buying an estimated $14.5K and bringing the position to 24,409 shares worth $5.48M. The position accounts for 0.1% of the portfolio, ranked #201.
Perigon Wealth Management first reported a position in RMD in Q2 2016 and has held it in 35 quarters since. The position peaked at $7.24M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Perigon Wealth Management held 24,409 shares of ResMed worth $5.48M as of Q1 2026.
- Perigon Wealth Management bought 58 ResMed shares in Q1 2026, an estimated $14.5K.
- ResMed made up 0.1% of Perigon Wealth Management's portfolio in Q1 2026, its #201 holding.
- Perigon Wealth Management first reported a position in ResMed in Q2 2016 and has held it in 35 quarters since.
- Perigon Wealth Management's ResMed position peaked at $7.24M in Q3 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.